Clinical Trials Browser

Phase EARLY_PHASE1 × Celecoxib × 90 days × Clear all

NCT01881048 2026-01-29

Window of Opportunity Study Targeting the Inflammatory Milieu

Phase EARLY_PHASE1 Completed

Breast Neoplasms